Xenon Pharmaceuticals (XENE) Tops Q3 EPS by 4c

Xenon Pharmaceuticals (NASDAQ: XENE) reported Q3 EPS of ($0.73), $0.04 better than the analyst estimate of ($0.77).

For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Darden Restaurants (DRI) PT Raised to $240 at UBS as Stock Remains a 'Quality Compounder'
• Mount Logan Capital to join Russell Microcap Index on June 29